Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

12
Number of overlapping holdings
29.3%
% of XPH's 41 holdings also in PJP
52.2%
% of PJP's 23 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XPH |
Weight in PJP |
Overlap | |
---|---|---|---|---|
MERCK & CO. INC. | 4.2% | 6.7% | 4.2% | |
JOHNSON & JOHNSON | 4.0% | 6.1% | 4.0% | |
ELI LILLY & CO | 4.0% | 6.1% | 4.0% | |
PERRIGO CO | 4.8% | 3.7% | 3.7% | |
PFIZER INC | 3.6% | 5.9% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PJP
REVANCE THERAPEUTICS INC | 5.6% | |
ORGANON & CO. | 4.8% | |
CATALENT INC | 4.6% | |
VIATRIS, INC. | 4.5% | |
ZOETIS INC | 4.4% | |
ELANCO ANIMAL HEALTH, INC. | 4.3% | |
AXSOME THERAPEUTICS, INC. | 3.9% | |
BRISTOL-MYERS SQUIBB CO | 3.9% | |
ROYALTY PHARMA PLC CLASS A | 3.8% | |
CASSAVA SCIENCES, INC. | 3.7% |
XPH Underweight Relative to PJP
ABBOTT LABORATORIES | -6.9% | |
GILEAD SCIENCES INC | -6.3% | |
ABBVIE INC | -6.1% | |
AMGEN INC | -5.8% | |
HORIZON PHARMA PLC | -4.8% | |
EMERGENT BIOSOLUTIONS INC | -3.6% | |
TRAVERE THERAPEUTICS, INC. | -3.4% | |
UNITED THERAPEUTICS CORP | -3.2% | |
REGENERON PHARMACEUTICALS | -3.2% | |
BIOGEN IDEC INC | -3.1% |